The Effects of GMA-TULIP, I-gel, and BlockBuster Laryngeal Mask in Surgeries With Lateral Position Under General Anesthesia

To compare the efficacy and safety of traditional inflatable laryngeal mask, i-gel non-inflatable laryngeal mask and GMA-TULIP non-inflatable laryngeal mask in surgeries with lateral position under general anesthesia, so that providing evidence for the selection of laryngeal mask in surgeries with lateral position.

Study Overview

Detailed Description

Laryngeal mask and tracheal intubation are the two most commonly used airway management methods for patients under general anesthesia. Compared with tracheal intubation, laryngeal mask is only placed in the throat without the need for laryngoscope to expose the glottis, not entering the glottis and trachea, so it will not cause mechanical damage to the vocal cords and trachea. Moreover, the insertion of laryngeal mask reduces the excitation of sympathetic and vagus nerves, has a relatively mild effect on physiological status, and significantly reduces cardiovascular reactions, which is convenient for maintaining hemodynamic stability during anesthesia induction and patients can tolerate the tube better without coughing or agitation during recovery from the anesthesia. Therefore, laryngeal masks are currently widely used in airway management during general anesthesia. Studies have shown that about 3 million patients in the UK National Health Service system receive anesthesia surgery with different types of airway management every year, and the use of laryngeal masks is higher than that of tracheal intubation, accounting for about 56.2%.

Since its introduction, many new laryngeal masks have been improved and applied to clinical practice based on the classic laryngeal mask. A key indicator for evaluating the performance of laryngeal masks is their sealing effect on the airway. Currently, laryngeal masks are mainly divided into two categories: inflatable laryngeal masks and non-inflatable laryngeal masks. Inflatable laryngeal masks are traditional types, including BlockBuster, Superme, ProSeal, and Fastrach, which are the most widely used in clinical practice. Non-inflatable laryngeal masks are designed with a mirror image of the throat opening and use thermoplastic elastomer materials to achieve a gas tightness effect similar to that of inflatable laryngeal masks. The i-gel laryngeal mask is currently the most commonly used non-inflatable type. A meta-analysis found that the sealing pressure of the i-gel laryngeal mask is higher than that of traditional inflatable laryngeal masks, indicating better airway sealing performance for non-inflatable laryngeal masks. The GMA-TULIP non-inflatable laryngeal mask is a new type of non-inflatable laryngeal mask with advantages such as a C-shaped double gastric tube channel, a stable platform for the tongue base, a soft tissue sealing ring, a prominent epiglottis attachment, and a design that matches the anatomical structure of the throat opening. Compared with inflatable laryngeal masks, the GMA-TULIP mask is more in line with anatomical positioning design, theoretically providing higher sealing effect on the airway.

Although the laryngeal mask has been successfully applied to the airway management of surgeries with lateral position under general anesthesia, its widespread use is limited due to the special position of lateral position, which may lead to laryngeal mask displacement, poor airway tightness, and air leakage. Therefore, exploring a laryngeal mask with better airway sealing effect in surgeries with lateral position under general anesthesia will help promote the clinical application of laryngeal mask, reduce airway injury and hemodynamic fluctuation, and improve patient comfort. To this end, this project plans to compare the application effects of traditional inflatable BlockBuster laryngeal mask, i-gel non-inflatable laryngeal mask, and GMA-TULIP non-inflatable laryngeal mask in surgeries with lateral position under general anesthesia, providing clinical evidence for the selection of laryngeal mask in surgeries with lateral position under general anesthesia.

Study Type

Interventional

Enrollment (Estimated)

102

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Chongqing
      • Chongqing, Chongqing, China, 400000
        • Recruiting
        • The Second Affiliated Hospital of Chongqing Medical University
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  1. Patients received surgeries in lateral position with an estimated surgery duration of less than 3 hours under general anesthesia.
  2. Ages between 18 to 80, and body mass index less than 28 kg/m².
  3. American Society of Anesthesiologists (ASA) Grades I-III.
  4. Patients are willing to participate and be able to understand and sign an informed consent form.

Exclusion Criteria:

  1. Individuals with an open bite of less than 2cm.
  2. Individuals with a history of obvious regurgitation of gastric contents and risk factors for aspiration.
  3. Patients with combined pharyngeal and laryngeal lesions.
  4. Predicting difficult airway patients.
  5. Hearing, intellectual, communication, and cognitive impairments.
  6. Any reason that prevents cooperation with the study or that the researcher deems inappropriate for inclusion in this trial.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: GMA-TULIP Laryngeal Mask Group(D1 Group)
After the anesthesia induction, use the GMA-TULIP laryngeal mask as the airway ventilation device.
After the anesthesia induction, use the GMA-TULIP laryngeal mask as the airway ventilation device.
Active Comparator: i-gel Laryngeal Mask Group(D2 Group)
After the anesthesia induction, use the i-gel laryngeal mask as an airway ventilation device.
After the anesthesia induction, use the i-gel laryngeal mask as an airway ventilation device.
Active Comparator: BlockBuster Laryngeal Mask Group(D3 Group)
After the anesthesia induction is over, use the BlockBuster laryngeal mask as the airway ventilation device.
After the anesthesia induction is over, use the BlockBuster laryngeal mask as the airway ventilation device.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
oropharyngeal leak pressure
Time Frame: 1 minute after the laryngeal mask is successful inserted, 5 and 30 minutes after the lateral position
After the laryngeal mask is successful inserted, set the fresh gas flow to 3 L/min in manual mode, turn the APL valve to 30 cmH2O, then listen to the neck. When hearing the sound of air leakage, the peak airway pressure at this time is the oropharyngeal leak pressure.
1 minute after the laryngeal mask is successful inserted, 5 and 30 minutes after the lateral position

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The rate of first-insertion success
Time Frame: 1 minute after the first-attempt insertion of the laryngeal mask
The successful insertion is defined as oropharyngeal leak pressure higher than 20 cmH2O and grade 1-2 of the laryngeal view under the fibreoptic bronchoscopy (indicating the accuracy of laryngeal mask positioning).
1 minute after the first-attempt insertion of the laryngeal mask
The rate of total-insertion success
Time Frame: 1 minute after the airway is successfully controlled.
The total successful insertion is defined as ventilation with the allocated laryngeal mask after anesthesia induction
1 minute after the airway is successfully controlled.
Time of insertion
Time Frame: 1 minute after successful insertion of the laryngeal mask
Insertion time was defined as the time from the opening of the mouth by the operator to the positively insert the laryngeal mask. The time of glottic examination, adjustment between two ventilation insertions, and ventilation was not measured as ventilation insertion time.
1 minute after successful insertion of the laryngeal mask
Times of laryngeal mask adjustment before the successful insertion
Time Frame: 1 minute after the airway is successfully controlled.
The times of laryngeal mask adjustments before successful laryngeal mask insertion.
1 minute after the airway is successfully controlled.
Success rate of gastric tube insertion through laryngeal mask
Time Frame: 1 minute after the laryngeal mask is successful inserted
After the laryngeal mask is successful inserted, a fully lubricated 14F gastric tube was inserted through its esophageal drainage tube
1 minute after the laryngeal mask is successful inserted
Airway plateau pressure
Time Frame: 1 minute after the laryngeal mask is successful inserted, 5 and 30 minutes after the lateral position
Plateau airway pressure refers to the pressure that a certain amount of gas remains in the lungs against the entire closed system at the end of the passage of air, before the beginning of exhalation. Airway plateau pressure was measured by the anesthesia machine automatically.
1 minute after the laryngeal mask is successful inserted, 5 and 30 minutes after the lateral position
Peak airway pressure
Time Frame: 1 minute after the laryngeal mask is successful inserted, 5 and 30 minutes after the lateral position
Peak pressure refers to the maximum pressure produced by the airflow in the closed circuit each time the ventilator delivers a certain amount of gas from the endotracheal tube to the patient's lungs. Peak airway pressure was measured by the anesthesia machine automatically.
1 minute after the laryngeal mask is successful inserted, 5 and 30 minutes after the lateral position
grade of view on fibreoptic bronchoscopy (indicating the accuracy of laryngeal mask positioning)
Time Frame: 1 minute after the laryngeal mask is successful inserted, 5 and 30 minutes after the lateral position
After successful insertion of the laryngeal mask, fiberoptic bronchoscopy was used and graded according to the degree of glottic and epiglottis exposure by a 4-point scale system: 1, full view of glottis; 2, vocal cords, arytenoids, and inferior surface of epiglottis visible; 3, only superior surface of epiglottis visible; 4, no part of epiglottis or larynx visible. The grades 1 and 2 were defined as optimal fiberscopic view.
1 minute after the laryngeal mask is successful inserted, 5 and 30 minutes after the lateral position
Times of laryngeal mask adjustment during the operation
Time Frame: From 1 minute after the beginning of anesthesia to 1 minute after the end of anesthesia
the times of the laryngeal mask adjustment during the operation were recorded
From 1 minute after the beginning of anesthesia to 1 minute after the end of anesthesia
Times of intraoperative air leakage
Time Frame: From 1 minute after the beginning of anesthesia to 1 minute after the end of anesthesia
intraoperative air leakage is defined as hearing the sound of air leakage at the neck during the operation
From 1 minute after the beginning of anesthesia to 1 minute after the end of anesthesia
Active mouth bleeding rate
Time Frame: 1 minute after laryngeal mask removal
After the laryngeal mask was removed, record whether active bleeding occurred at the patient's mouth
1 minute after laryngeal mask removal
incidence of blood staining on the laryngeal mask
Time Frame: 1 minute after the laryngeal mask was withdrawn
When the laryngeal mask was pulled out, the laryngeal mask was stained with blood
1 minute after the laryngeal mask was withdrawn
The incidence of regurgitation
Time Frame: From 1 minute after the beginning of anesthesia to 1 minute after the end of anesthesia
The regurgitation is defined as seeing the gastric content in the mouth
From 1 minute after the beginning of anesthesia to 1 minute after the end of anesthesia
The incidence of aspiration
Time Frame: From 1 minute after the beginning of anesthesia to 1 minute after the end of anesthesia
The aspiration is defined as seeing the gastric content in the trachea
From 1 minute after the beginning of anesthesia to 1 minute after the end of anesthesia
The incidence of cough
Time Frame: From 5 minutes before to 5 minutes after the laryngeal mask withdrawal.
When the laryngeal mask was pulled out, record whether the patient has cough or not.
From 5 minutes before to 5 minutes after the laryngeal mask withdrawal.
Severity of sore throat
Time Frame: 10 minutes, 2 hours, 24 hours, 48 hours, and 72 hours after surgery
The Prince-Henry score was used to evaluate the degree of sore throat: 0, no pain when coughing; 1, pain only when coughing; 2, pain when breathing deeply, but not at rest; 3, pain at rest, but mild and tolerable; 4, excruciating pain at rest, respectively.
10 minutes, 2 hours, 24 hours, 48 hours, and 72 hours after surgery
Length of surgery
Time Frame: 1 minute after the end of surgery
The end of the surgery time minus the start of the surgery time
1 minute after the end of surgery
Time of laryngeal mask application
Time Frame: 1 minute after the laryngeal mask is withdrawn
The time of laryngeal mask withdrawn minus the time of successful laryngeal mask insertion is the time of laryngeal mask application
1 minute after the laryngeal mask is withdrawn
The incidence of hoarseness
Time Frame: 10 minutes, 2 hours, 24 hours, 48 hours, and 72 hours after surgery
Record whether the patient is hoarse when speaking
10 minutes, 2 hours, 24 hours, 48 hours, and 72 hours after surgery
The incidence of dysphagia
Time Frame: 10 minutes, 2 hours, 24 hours, 48 hours, and 72 hours after surgery
Check the patient can swallow or not
10 minutes, 2 hours, 24 hours, 48 hours, and 72 hours after surgery
Heart rate
Time Frame: 1 minute before laryngeal mask insertion or withdrawn, and 1 minute after the laryngeal mask is inserted or withdrawn
Heart rate
1 minute before laryngeal mask insertion or withdrawn, and 1 minute after the laryngeal mask is inserted or withdrawn
systolic blood pressure
Time Frame: 1 minute before laryngeal mask insertion or withdrawn, and 1 minute after the laryngeal mask is inserted or withdrawn
systolic blood pressure
1 minute before laryngeal mask insertion or withdrawn, and 1 minute after the laryngeal mask is inserted or withdrawn
diastolic blood pressure
Time Frame: 1 minute before laryngeal mask insertion or withdrawn, and 1 minute after the laryngeal mask is inserted or withdrawn
diastolic blood pressure
1 minute before laryngeal mask insertion or withdrawn, and 1 minute after the laryngeal mask is inserted or withdrawn
mean arterial pressure
Time Frame: 1 minute before laryngeal mask insertion or withdrawn, and 1 minute after the laryngeal mask is inserted or withdrawn
mean arterial pressure
1 minute before laryngeal mask insertion or withdrawn, and 1 minute after the laryngeal mask is inserted or withdrawn

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Bing Chen, The Second Affiliated Hospital of Chongqing Medical University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 21, 2024

Primary Completion (Estimated)

June 1, 2026

Study Completion (Estimated)

June 1, 2026

Study Registration Dates

First Submitted

January 5, 2025

First Submitted That Met QC Criteria

January 14, 2025

First Posted (Actual)

March 25, 2025

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

January 14, 2025

Last Verified

July 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • 2024.134

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

Individual participant data (IPD) will be available with the responding author when required.

IPD Sharing Time Frame

The data will become available when publish and keep it for 5 years.

IPD Sharing Access Criteria

Researchers who provide a methodologically sound proposal.

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP
  • ICF
  • ANALYTIC_CODE
  • CSR

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Oropharyngeal Leak Pressure

Clinical Trials on GMA-TULIP Laryngeal Mask

Subscribe